ArticleCureus2023

Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs).

Akiko Koizumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.